Literature DB >> 27349945

Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.

Kiva Brennan1, Brian P McSharry1, Sinéad Keating1, Andreea Petrasca2, Vincent P O'Reilly2, Joseph Keane3, Derek G Doherty2, Clair M Gardiner4.   

Abstract

NKG2D is an important activating receptor expressed on NK cells. Ligands (termed NKG2DL) for this receptor include ULBP1-6, MICA and MICB in humans; they are upregulated in stressed, cancerous or infected cells where they engage NKG2D to induce NK cell cytotoxicity and cytokine production. Expression of NKG2DL on effector cells has been described in mice and more recently in human cells. We confirm that NK cell lines and IL-2 stimulated primary human NK cells also express the NKG2DL, ULBP2. However, expression of ULBP2 was not a result of transfer from a non-NK cell to an NK cell and in contrast to recent reports we saw no evidence that ULBP2 expression targeted these NK cells for fratricide or for cytotoxicity by NKG2D-expressing, non-NK effector cells. ULBP2 expression was however linked to expression of mature CD57(+) NK cells. In particular, expression of ULBP2 was strongest on those NK cells that had evidence of recent activation and proliferation. We suggest that ULBP2 could be used to identify recently activated "mature" NK cells. Defining this phenotype would be useful for understanding the ontogeny on human NK cells.
Copyright © 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human; NKG2D; Natural Killer cells; Phenotype; ULBP2

Mesh:

Substances:

Year:  2016        PMID: 27349945     DOI: 10.1016/j.humimm.2016.06.018

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

1.  An immune-related risk gene signature predicts the prognosis of breast cancer.

Authors:  Wenning Cao; Yike Jiang; Xiang Ji; Lan Ma
Journal:  Breast Cancer       Date:  2021-01-05       Impact factor: 4.239

2.  NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.

Authors:  Neekun Sharma; Camille V Trinidad; Andrew P Trembath; Mary A Markiewicz
Journal:  J Immunol       Date:  2017-09-11       Impact factor: 5.422

Review 3.  Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Authors:  Antonio Valeri; Almudena García-Ortiz; Eva Castellano; Laura Córdoba; Elena Maroto-Martín; Jessica Encinas; Alejandra Leivas; Paula Río; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

Review 4.  More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Authors:  Andrew P Trembath; Mary A Markiewicz
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.